ResearcherCapital Medical UniversityNo recent work listed

Xiao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4688-2657; OpenAlex author ID A5100664451. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR Pathway. Co-author DOI 10.3389/fphar.2019.00319 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiukun Lin · 1 shared paper, 2019 · strength 0.10
- Paper Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR … DOI 10.3389/fphar.2019.00319 ↗
Huanli Xu · 1 shared paper, 2019 · strength 0.10
- Paper Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR … DOI 10.3389/fphar.2019.00319 ↗
Ammad Ahmad Farooqı · 1 shared paper, 2019 · strength 0.10
- Paper Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR … DOI 10.3389/fphar.2019.00319 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.